Database and Biobank of Patients With Hypersensitivity Pneumonitis
ConditionHypersensitivity Pneumonitis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNils Hoyer
About this trial
Sub-study of the main Pulmonary Fibrosis Biomarker (PFBIO) cohort (NCT02755441), recruiting patients with an MDT-diagnosis of hypersensitivity pneumonitis (HP). Patients are included for the collection of blood samples and regular clinical data.
The database and biobank will be available for studies of HP, and can be directly compared to the main PFBIO cohort, which has recruited patients with Idiopathic pulmonary Fibrosis (IPF) since 2016.
Biomarkers will be assessed as diagnostic and prognostic. Further subtyping of HP, based on blood markers (including precipitins) will also be possible with the PFBIO-HP project.
Eligibility criteria
Qualifiers
Diagnosis of HP at an MDT conference according to the current international guidelines
Age of 18 years or older
The patients must be capable of giving informed consent
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
50 Participants
are grouped into 1 trial groupSponsors and collaborators
Nils Hoyer
Lead sponsor
University Hospital, Gentofte, Copenhagen
Sponsor institution
Source ClinicalTrials.gov